Literature DB >> 14534916

Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy.

Christian Brenneis1, Klaus Seppi, Michael F Schocke, Jörg Müller, Elisabeth Luginger, Sylvia Bösch, Wolfgang N Löscher, Christian Büchel, Werner Poewe, Gregor K Wenning.   

Abstract

To determine magnetic resonance imaging (MRI) patterns of brain atrophy in parkinsonian syndromes, we applied voxel-based morphometry (VBM) to segmented gray matter, white matter, and cerebrospinal fluid compartments of T(1)-weighted brain volumes of 12 patients with probable multiple system atrophy-parkinson variant (MSA-P) and 12 Parkinson's disease patients, comparing them with 12 normal controls matched for age. In comparison to controls, a cortical atrophy pattern was observed in MSA-P patients with significant clusters of volume loss in primary sensorimotor cortices bilateral, supplementary motor areas bilateral, right premotor cortex, prefrontal cortex bilateral (middle frontal gyri) and insular cortices bilateral; subcortical atrophy occurred bilaterally in caudate nuclei and putamen as well as in the midbrain. Furthermore, an enlargement of the cerebrospinal fluid compartment was found in the lateral ventricles, third ventricle, perimesencephalic and cerebellomedullar cavities. In PD patients, significant atrophy only occurred in left caudate head with enlargement of left lateral ventricle. Comparing MSA-P to PD patients, MSA-P showed a similar cortical pattern of atrophy as compared to controls. We conclude that VBM reveals selective cortical atrophy in patients with MSA-P affecting primary and higher order motor areas as well as prefrontal and insular cortices. Further studies are required to determine clinical and/or subclinical correlates of cortical atrophy in MSA-P. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534916     DOI: 10.1002/mds.10502

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  54 in total

1.  Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: a voxel-based morphometry study.

Authors:  Jing Zhang; Yun-Ting Zhang; Wei-Dong Hu; Li Li; Guang-Yao Liu; Yu-Ping Bai
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

3.  Tracking the neurodegeneration of parkinsonian disorders--a pilot study.

Authors:  C Nilsson; K Markenroth Bloch; S Brockstedt; J Lätt; H Widner; E-M Larsson
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

4.  Morphological differences in Parkinson's disease with and without rest tremor.

Authors:  David H Benninger; Sebastian Thees; Spyros S Kollias; Claudio L Bassetti; Daniel Waldvogel
Journal:  J Neurol       Date:  2009-02-04       Impact factor: 4.849

5.  Callosal tissue loss in multiple system atrophy--a one-year follow-up study.

Authors:  Martina Minnerop; Eileen Lüders; Karsten Specht; Jürgen Ruhlmann; Nicole Schimke; Paul M Thompson; Yi Y Chou; Arthur W Toga; Michael Abele; Ullrich Wüllner; Thomas Klockgether
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

6.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

7.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

Review 8.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

9.  Response monitoring in de novo patients with Parkinson's disease.

Authors:  Rita Willemssen; Thomas Müller; Michael Schwarz; Michael Falkenstein; Christian Beste
Journal:  PLoS One       Date:  2009-03-27       Impact factor: 3.240

10.  Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.

Authors:  Anthony C Vernon; Saga M Johansson; Michel M Modo
Journal:  BMC Neurosci       Date:  2010-01-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.